Australia's largest stock trading and investment forum Australia's #1 stock forum

GMV

Click for more information

0.00%

3.9¢ g medical innovations holdings limited

Ann: Proposed IPO of China Subsidiary in Hong Kong, page-324

First 324 Last

Share
Profile

Follow
Glyco

6,165 Posts.

2345

24/09/18

14:33

Post #: 35801765
Share

Originally posted by Mazer ↑

Hi Team

Discussing GMV with another investor recently they expressed some concerns re. the HKSE listing raising the required capital. Fair question. I'm hardly the best person to answer this question, maybe one of our GMVers would like to comment?

Below is some info surrounding the info taken from the announcement 8th August 2018.

Apologies if this topic has appeared earlier in this thread.

Cheers
Mazer
=======================================
From GMV announcement: The management of G Medical have appointed global Investment Bank, UOB Kay Hian (Hong Kong) Limited (UOB to act as the financial adviser.

UOB
Founded by Datuk Wee Kheng Chiang, UOB was incorporated on 6 August 1935 as the United Chinese Bank; the change of name was effected in 1965. The Bank catered mainly to the Fujian community in its early years but over the past decades, UOB has grown in strength and stature. Through a series of acquisitions, it is now a leading bank in Asia. Besides Far Eastern Bank in Singapore, UOB’s major banking subsidiaries in the region are United Overseas Bank (Malaysia), United Overseas Bank (Thailand), PT Bank UOB Indonesia and United Overseas Bank (China). Today, the UOB Group has a network of more than 500 offices in 19 countries and territories in Asia Pacific, Western Europe and North America.
https://www.uob.com.sg/uobgroup/about/story/our-corporate-profile.page

From GMV ann: "... G Medical cautions investors that there can be no certainty that the proposed IPO will proceed and that the listing is subject to satisfaction of all legal and regulatory requirements in Australia and Hong Kong,..."

HKSE integrity [good for GMV?]
Alibaba held its record $25 billion public float in New York in 2014 after Hong Kong, its favoured venue, refused to accept its governance structure where a self-selecting group of senior managers control the majority of board appointments.
https://www.cnbc.com/2018/01/09/ali...nsider-hong-kong-listing-says-founder-ma.html

HKSE IPO's
2018 will be a "very strong year" for IPOs in the city, according to JPMorgan's Gu. More financial technology, consumer and health-care companies will come to market next year, said Mille Cheng, co-head of Asia Pacific equity capital markets at Morgan Stanley.

"Investors will continue to focus on growth, with tech and health care likely the darlings again,"
https://www.businesstimes.com.sg/st...to-hong-kong-ipos-in-us163b-bonanza-this-year

"Hong Kong’s stock exchange has set a goal of overtaking New York’s Nasdaq within five years in terms of the number of listings of mainland Chinese biotechnology companies and their market capitalisation, according to HKEX chief executive Charles Li Xiaojia.
The declining trend came after funds raised at IPO in Hong Kong in 2017 fell 45% to US$13.87 billion, the lowest level since 2012, according to Thomson Reuters data.
A lack of big tech-related stocks and other blockbuster capital raising are among the reasons Hong Kong lost its global IPO market crown – a title it retained in 2015 and 2016. In 2017, the city slid to the No 3 spot globally for IPOs, overtaken by New York and Shanghai."
https://www.scmp.com/business/compa...third-globally-ipos-q1-funds-raised-fell-26pc

Cayman Islands address explained?
"Other than companies incorporated in Hong Kong, the HKSE has, as of May 2018, recognised companies incorporated in the People’s Republic of China (PRC), the Cayman Islands and Bermuda as ‘eligible’ for listing. The relevant listing applicant incorporated in any of these jurisdictions is not required to make specific submissions to seek the HKSE’s approval insofar as jurisdiction of incorporation is concerned ."
https://gettingthedealthrough.com/area/78/jurisdiction/40/initial-public-offerings-2019-hong-kong/

GMV Ann: Under the terms of the Agreement, UOB will obtain an in-principle approval from the Hong Kong Stock Exchange to proceed with the listing application, with the initial market capitalisation of GYIMSTC Ltd to be at least HK$1,500,000,000 (~A$260 million), as required under the Hong Kong Stock Exchange Listing Rules for biotech companies (Chapter 18A provisions).
http://en-rules.hkex.com.hk/en/display/display_main.html?rbid=4476&element_id=5193

Expand

@Mazer
There are lots of info on HKEx in this thread.
re
"... G Medical cautions investors that there can be no certainty that the proposed IPO will proceed and that the listing is subject to satisfaction of all legal and regulatory requirements in Australia and Hong Kong,..."

IPO is never a certainty until it actually happens.

An alternative to a HK'IPO is... if a big china big player (CBP, say Alibaba or JD.Com) decides to take a stake in Gyim:
Gmv-SinoJv-CBP
55-25-20%

(imo, Yacov prefers a HKIP to maximize shh wealth)

We will find out in a few months from UOB who will make it happen.
We can expect at least 6 major events in next 6 months, leading to IPO.
cheers
~~~~~

~
Alibaba injects pharmacy assets into healthcare unit in $1.4 billion ...

https://www.reuters.com/...alibaba-health/alibaba-injects-pharmacy-assets-into-healthc...
May 28, 2018 -

.
DIGITAL HEALTH BRIEFING: Alibaba doubles down on AI for ...

https://www.*.com/digital-health-briefing-alibaba-doubles-down-on-ai-f...
May 18, 2018 - Alibaba Health reveals plans to expand expand investments in AI. Healthcare AI tools and services will enable Alibaba to take advantage of a ...

.
Alibaba Health, Merck Team Up on China Healthcare Services | Alizila ... https://www.alizila.com/alibaba-health-merck-china/
Jun 20, 2018 - Alibaba Health and Merck signed an agreement to provide Chinese patients with better access to patient-centric healthcare services.

.
At war with Alibaba: Top brands fight China e-commerce giant

https://www.cnbc.com/.../at-war-with-alibaba-top-brands-fight-china-e-commerce-gia...
Apr 23, 2018 -
As the Trump administration pushes China to play by fair trade rules,
... The competition between Alibaba and JD.com is so infamous in China ...
.

Last edited by Glyco: 24/09/18

GMV Price at posting: 36.0¢ Sentiment: Buy Disclosure: Held
12 Upvote

3 Great analysis

Reply

Top Stories

CBA breaks trading record on strong day for Aussie financials

QML

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

LAM

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

As Nvidia cools, we're looking to Aussie AI

PRU

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

RMX

Red Mountain Mining: record gold prices, two projects, two greenstone belts

SBW

Shekel Brainweigh investor presentation webinar – the future of retail automation

BIT

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

OCC

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

There are more pages in this discussion • 2 more messages in this thread...

First 324 Last

Add GMV (ASX) to my watchlist